StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.47−0.05 (-0.32%)

Close on Nov 20, 2026Market cap $83.29MP/E 3.4Yield –

Rallybio shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Rallybio's shares outstanding was 6M at Sep 30, 2026. For fiscal 2025 it was 6M, up 3.4% from the year before. The highest annual figure on record is 6M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20256M+3.4%
FY2024Dec 31, 20245M+7.7%
FY2023Dec 31, 20235M+27.1%
FY2022Dec 31, 20224M+24.7%
FY2021Dec 31, 20213M+46.8%
FY2020Dec 31, 20202M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 20266M+1.5%
Q2 FY2026Jun 30, 20266M+3.4%
Q1 FY2026Mar 31, 20266M+1.6%
Q4 FY2025Dec 31, 20256M+1.8%
Q3 FY2025Sep 30, 20256M+1.0%
Q2 FY2025Jun 30, 20256M+1.6%
Q1 FY2025Mar 31, 20256M+9.8%
Q4 FY2024Dec 31, 20246M+9.9%
Q3 FY2024Sep 30, 20246M+10.0%
Q2 FY2024Jun 30, 20246M+9.3%
Q1 FY2024Mar 31, 20245M+1.3%
Q4 FY2023Dec 31, 20235M+14.2%
Q3 FY2023Sep 30, 20235M+31.7%
Q2 FY2023Jun 30, 20235M+32.0%
Q1 FY2023Mar 31, 20235M+32.8%
Q4 FY2022Dec 31, 20224M+18.5%
Q3 FY2022Sep 30, 20224M+11.8%
Q2 FY2022Jun 30, 20224M+35.6%
Q1 FY2022Mar 31, 20224M+36.3%
Q4 FY2021Dec 31, 20214M+35.1%
Q3 FY2021Sep 30, 20213M+24.3%
Q2 FY2021Jun 30, 20213M+36.5%
Q1 FY2021Mar 31, 20213M–
Q4 FY2020Dec 31, 20203M–
Q3 FY2020Sep 30, 20203M–
Q2 FY2020Jun 30, 20202M–

More Rallybio figures

See a number that looks wrong?